The Report
Verified funding, headquarters, and leadership news from the world's most innovative businesses
4,865 reports and counting
Legora Raises $550M Series E at $8.8B Valuation
Legora raised a $550 million Series E at an $8.8 billion post-money valuation, led by Atreides Management.
Rightway Raises $155M Series E Led by Francisco Partners
Rightway raised a $155 million Series E led by Francisco Partners to expand its AI capabilities and the technology behind its pharmacy benefits model.
Ridgeline Raises $250M Series E at a $1.425B Valuation
Ridgeline raised a $250 million Series E led by founder Dave Duffield, valuing its AI-native investment-management platform at $1.425 billion.
Temporal Raises $550M Series E at a $12.55B Valuation
Temporal raised a $550 million Series E at a $12.55 billion valuation, led by Lightspeed, to fund platform R&D and developer and enterprise go-to-market.
Stoke Space Raises $1B Series E for Reusable Launch Vehicles
Stoke Space completed an initial closing of a $1 billion Series E co-led by Point72 Ventures and Spark Capital to advance its fully reusable launch vehicles and launch infrastructure.
Thyme Care Closes $125M+ Series E and Establishes Thyme Companies
Thyme Care raised more than $125 million in a Series E led by Morgan Health at a valuation of more than $2 billion and established Thyme Companies to build new oncology businesses.
PLL Raises $100M Series E Led by Ares and Joe Tsai
The Premier Lacrosse League raised a $100 million Series E led by Ares and Joe Tsai to expand media distribution, sponsorships, the Women’s Lacrosse League and youth access.
Current Raises $80M Series E for Consumer Fintech Platform
Current raised an $80 million Series E at a $1.5 billion valuation led by Springcoast Partners to expand its consumer banking, payments, liquidity, and credit products.
GT Medical Technologies Raises $100M Series E for Brain Tumor Radiotherapy Implant
GT Medical Technologies raised a $100 million Series E led by new investor Viking Global Investors to accelerate commercial and operational initiatives for its GammaTile brain tumor therapy.
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.